findmyKOL
Clinical trialNCT02686645UnknownPhase 2/PHASE3Interventional

Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection

SponsorQueen Elizabeth II Health Sciences CentreEnrollment50Clostridium Difficile Infection
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Ian R Davis, MD,FRCPC

    Dalhousie University, Department of Medicine, Division Infectious Diseases

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2016
Primary completion
31 Dec 2021
Completion
31 Dec 2021
Last update posted
27 Sept 2016
Registered enrollment
50
Registry id
NCT02686645

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.